• 129 Citations
  • 6 h-Index
20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Atelda Romano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Biosimilar Pharmaceuticals Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Hematopoietic Stem Cell Mobilization Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Iron Overload Medicine & Life Sciences
Autografts Medicine & Life Sciences
Transplants Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 129 Citations
  • 6 h-Index
  • 22 Article
  • 1 Letter
  • 1 Review article

A Survey on Pituitary Surgery in Italy

Solari, D., Zenga, F., Angileri, F. F., Barbanera, A., Berlucchi, S., Bernucci, C., Carapella, C., Catapano, D., Catapano, G., Cavallo, L. M., D'Arrigo, C., de Angelis, M., Denaro, L., Desogus, N., Ferroli, P., Fontanella, M. M., Galzio, R. J., Gianfreda, C. D., Iacoangeli, M., Lauretti, L. & 19 others, Locatelli, D., Locatelli, M., Luglietto, D., Mazzatenta, D., Menniti, A., Milani, D., Nasi, M. T., Romano, A., Ruggeri, A. G., Saladino, A., Santonocito, O., Schwarz, A., Skrap, M., Stefini, R., Volpin, L., Wembagher, G. C., Zoia, C., Zona, G. & Cappabianca, P., 2019, In : World Neurosurgery. 123, p. e440-e449

Research output: Contribution to journalArticle

Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?

Di Veroli, A., Campagna, A., De Muro, M., Maurillo, L., Trawinska, M. M., LeonettiCrescenzi, S., Petriccione, L., Romano, A., D'Addosio, A., Cenfra, A., Montanaro, M., Felici, S., Andriani, A., Carmosino, I., Niscola, P., Montefusco, E., Breccia, M. & Latagliata, R., Jan 2019, In : Leukemia Research. 76, p. 65-69 5 p.

Research output: Contribution to journalArticle

Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?

Veroli, A. D., Campagna, A., Muro, M. D., Maurillo, L., Trawinska, M. M., LeonettiCrescenzi, S., Petriccione, L., Romano, A., D'Addosio, A., Cenfra, A., Montanaro, M., Felici, S., Andriani, A., Carmosino, I., Niscola, P., Montefusco, E., Breccia, M. & Latagliata, R., Jan 1 2019, In : Leukemia Research. 76, p. 65-69 5 p.

Research output: Contribution to journalArticle

Iron Overload
Ferritins
Neoplasms
Therapeutics
deferasirox

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure: Journal of Hepatology

NAVIGATORE-Lombardia and Veneto Study Groups, Degasperi, E., Spinetti, A., Lombardi, A., Landonio, S., Rossi, M. C., Pasulo, L., Pozzoni, P., Giorgini, A., Fabris, P., Romano, A., Lomonaco, L., Puoti, M., Vinci, M., Gatti, F., Carolo, G., Zoncada, A., Bonfanti, P., Russo, F. P., Aghemo, A. & 16 others, Soria, A., Centenaro, R., Maggiolo, F., Rovere, P., Pasin, F., Paon, V., Faggiano, G., Vario, A., Grossi, G., Soffredini, R., Carriero, C., Paolucci, S., Noventa, F., Alberti, A., Lampertico, P. & Fagiuoli, S., 2019, In : J. Hepatol.. 71, 6, p. 1106-1115 10 p.

Research output: Contribution to journalArticle